Znn3bq.jpeg
²é¿´: 804  |  »Ø¸´: 5
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

¹Å¿É¤×

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

[½»Á÷] FDAÅú×¼Spectral Diagnostics ¹«Ë¾¸Ä±ä¸Ã¹«Ë¾ToÖÎÁƸÐȾÐÔÐݿ˵ĺóÆÚÁÙ´²ÊÔÑé·½°¸ ÒÑÓÐ5È˲ÎÓë

Ô­ÎÄÁ´½Ó£ºhttp://www.reuters.com/article/2 ... ntent=Google+Reader
·­ÒëµÄ²»ºÃ£¬»¹Íû¾ÀÕýºÍº£º­£¬¹²Í¬Ìá¸ß

Spectral Diagnostics Inc said the U.S. health regulator approved a change in the design of a late-stage trial of its therapy for septic shock, to increase the study's ability to detect the treatment's effects.
Spectral Diagnostics£¨¹âÆ×Õï¶Ï£©¹«Ë¾±íʾ£¬ÃÀ¹úÎÀÉú¼à¹Ü»ú¹¹Åú×¼¸Ã¹«Ë¾ÖÎÁƸÐȾÐÔÐݿ˺óÆÚÁÙ´²ÊÔÑéÉè¼Æ·½°¸µÄ±ä¸ü£¬ÒÔÌá¸ßÁÙ´²Ñо¿Ë®Æ½´Ó¶ø½ÒʾÁÙ´²ÁÆÐ§¡£

The trial, named EUPHRATES, will now have two interim analyses instead of one.
¸ÃÁÙ´²ÊÔÑé³ÆÎªEUPHRATES£¬½«½øÐÐÁ½ÏîÁÙ´²ÖÐÆÚ·ÖÎö£¬¶ø·ÇÒ»Ïî¡£

It tests the company's Toraymyxin, which has been approved for therapeutic use in Japan and Europe, combined with the standard of care.
´ËÁÙ´²ÊÔÑéΪ½øÐиù«Ë¾ToraymyxinµÄÁÙ´²Ñо¿£¬¸ÃÒ©ÔÚÈÕ±¾ºÍÅ·ÖÞÒѾ­±»Åú×¼ÓÃÓÚÖÎÁƸÐȾÐÔÐݿˣ¬²¢½áºÏ±ê×¼»¤Àí½øÐÐÖÎÁÆ¡£

The company expects the trial to be fully enrolled by the end of 2014.
¸Ã¹«Ë¾Ô¤¼Æ2014ÄêÄêµ×½«Íê³ÉÁÙ´²ÊÔÑéÈ«²¿²¡ÀýµÄÈë×é¡£

Septic shock is a potentially dangerous fall in blood pressure because of the presence of bacteria.ÒòÓÐϸ¾ú´æÔÚ£¬¸ÐȾÐÔÐÝ¿ËÊÇѪѹϽµµÄDZÔÚ·çÏÕÒòËØ¡£

Based on the current rate of enrolment, Spectral will disclose results of the first analysis before the end of the first quarter of 2013, it said in a statement.
Ôڸù«Ë¾Ò»·ÝÉùÃ÷ÖУ¬»ùÓÚĿǰÁÙ´²ÊÔÑéµÄÈë×éÂÊ£¬¸Ã¹«Ë¾½«ÔÚ2013ÄêµÚÒ»¼¾¶Èǰ¹«²¼µÚÒ»ÆÚÁÙ´²ÊÔÑéµÄ·ÖÎö½á¹û£¬

Shares of the company closed at 24.5 Canadian cents on Tuesday on the Toronto Stock Exchange. ±¾Öܶþ£¬¸Ã¹«Ë¾¹É¼ÛÔÚ¶àÂ×¶à֤ȯ½»Ò×ËùµÄÊÕÅ̼ÛΪ24.5¼ÓԪÿ¹É¡£

[ Last edited by ¹Å¿É¤× on 2012-10-19 at 16:52 ]
»Ø¸´´ËÂ¥

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

·ÇÎáСÌìÏ£¬²Å¸ß¶øÒÑ£»·ÇÎá×ݹŽñ£¬Ê±¸³¶øÒÑ£»·ÇÎáíþ¾ÅÖÝ£¬ºê¹Û¶øÒÑ£»Èý·ÇÑÉ×ÎÞÃÎÖÁʤ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

okitworks

ľ³æ (ÖøÃûдÊÖ)

ÓÅÐã°æÖ÷

Êׯª¿ÆÑпìѶ£¬ÆÄÊÜÆô·¢¡£
5Â¥2012-10-20 09:12:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 6 ¸ö»Ø´ð

xunmeng1985

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¹ÅÇøÐÁ¿à£¡
̤ѩѰ÷£¬°Ù»¨Éî´¦£¡
6Â¥2012-10-20 12:25:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 277Çóµ÷¼Á +22 Äß½¨Éè 2026-04-06 22/1100 2026-04-12 18:18 by ѧzh
[¿¼ÑÐ] 296Çóµ÷¼Á +14 Íô£¡£¿£¡ 2026-04-10 16/800 2026-04-12 10:48 by zhouyuwinner
[¿¼ÑÐ] 274Çóµ÷¼ÁÇóµ÷¼Á +11 Jachenbingoo 2026-04-06 14/700 2026-04-11 11:37 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] 087100³õÊÔ311Çóµ÷¼Á +4 ÈÎÑÅÇÙ 2026-04-09 4/200 2026-04-11 10:33 by zhq0425
[¿¼ÑÐ] »¹Óл¯¹¤¶þÂÖµ÷¼ÁµÄѧУÂð 5+14 »¯¹¤ÈË999 2026-04-09 48/2400 2026-04-11 10:27 by 89436494
[¿¼ÑÐ] ±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ +11 LZH£¨µÈ´ýµ÷¼ÁÖÐ 2026-04-10 11/550 2026-04-11 08:39 by zhq0425
[¿¼ÑÐ] 291 Çóµ÷¼Á +29 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 29/1450 2026-04-10 22:55 by dick_runner
[¿¼²©] ²©Ê¿×Ô¼ö +7 ¿É¿ÉСÅÖ 2026-04-08 7/350 2026-04-10 08:28 by kimhero
[¿¼ÑÐ] 284Çóµ÷¼Á +7 ÈÃÎÒÉϰ¶°É°¢Î÷ 2026-04-09 7/350 2026-04-09 18:59 by haironglove
[¿¼ÑÐ] ¿¼Ñе÷¼Á +13 ±ù±ù£¬£¬£¬ 2026-04-07 13/650 2026-04-09 17:01 by Lilly_Li
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©µ÷¼Á +7 awwwwwooooo 2026-04-09 7/350 2026-04-09 13:31 by ±±¼«159263
[¿¼ÑÐ] ²ÄÁÏ307·ÖÇó´óÀÐ×éÊÕÁô +17 Hllºú 2026-04-07 17/850 2026-04-09 10:53 by liuhuiying09
[¿¼ÑÐ] Çóµ÷¼Á +3 ÖíÈâ¶Õ·ÛÌõcc 2026-04-08 4/200 2026-04-09 10:05 by ÖíÈâ¶Õ·ÛÌõcc
[¿¼ÑÐ] Ò»Ö¾Ô¸985³õÊÔ354·ÖÉúÎïµ÷¼Á +3 031001 2026-04-06 3/150 2026-04-09 00:30 by Evan_Liu
[¿¼ÑÐ] ²ÄÁÏ¿¼ÑÐÇóµ÷¼Á×Ü·Ö280 +30 mkjlz1 2026-04-06 35/1750 2026-04-08 21:25 by cyh¡ª315
[¿¼ÑÐ] ÍÁľˮÀûר˶276·ÖÇóµ÷¼Á +6 ÎÒÏëÉÏѧ£¡£¡6 2026-04-05 9/450 2026-04-08 17:45 by ËÎС±¦HQ
[¿¼ÑÐ] Çóµ÷¼Á +15 ÐܶþÏëÉϰ¶ 2026-04-06 15/750 2026-04-08 04:53 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] »úе¹¤³Ì264ѧ˶Çóµ÷¼Á +3 qiushangxian 2026-04-06 3/150 2026-04-08 01:53 by Linzejun
[¿¼ÑÐ] ±¾¿ÆÉúÎïÐÅϢѧ£¬×Ü·Ö362 Çó07 08µ÷¼Á +6 qСٻ1210 2026-04-06 6/300 2026-04-07 19:40 by macy2011
[¿¼ÑÐ] 372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ó¢¶þÊý¶þÇóµ÷¼Á +4 À¶¼ãƬ 2026-04-06 4/200 2026-04-07 12:30 by dongzh2009
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û